Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs

Table 3 Patterns of antimicrobial resistance of Enterobacteriaceae species isolated from UTIs

Antibiotic	AMC		CTZ		CRO		IMP		AK		SXT		NA		CIP		NOR		OFX		F
organism	N	%	N	%	N	%	N	%	N	%	N	%	N	%	N	%	N	%	N	%	N	%
E.coli	99	35.2	97	34.5	159	56.6	0	.0	63	22.4	182	64.8	104	37	54	19.2	54	19.2	54	19.2	69	24.6
K. pneumoniae	17	21.0	13	16.0	16	19.8	0	.0	9	11.1	29	35.8	11	13.6	9	11.1	9	11.1	9	11.1	12	14.8
Citrobacter spp.	31	66.0	20	42.6	30	63.8	0	.0	10	21.3	22	46.8	17	36.2	17	15.6	17	15.6	17	15.6	19	40.4
Enterobacter spp.	1	9.1	1	9.1	1	9.1	0	.0	1	9.1	2	18.2	1	9.1	0	0	0	0	0	0	0	0.0
Proteus spp.	11	55.0	11	55.0	11	55.0	0	.0	1	5.0	18	90.0	10	50	10	9.2	10	9.2	10	9.2	10	50
Total	159	36.1	142	32.3	217	49.3	0	.0	84	19.1	253	57.5	143	32.5	90	20.5	90	20.5	90	20.5	110	25

AMC Amoxicillin Clavulanic acid, CTZ Ceftazidime, CRO Ceftriaxone, IMP Imipenem, AK Amikacin, SXT Sulphamethoxazole-Trimethoprim, NA Nalidixic acid, CIP Ciprofloxacin, NOR Norfloxacin, OFX Ofloxacin, F Nitrofurantoin

ISSN: 1471-2334